$TDOC

Teladoc Health Inc (TDOC) (Q3 2026) Earnings Call Highlights: Integrated Care Margin

Teladoc Health (TDOC) reported Q3 2026 revenue of $605M, near guidance, with adjusted EBITDA of $79M, up 13.5% YoY. Integrated Care margins expanded 180 bps to 18.8%. BetterHelp insurance revenue hit $32M, but total revenue declined 3.4% YoY due to cash pay business headwinds. The company added 3,000 therapists, bringing total to 11,000. Free cash flow was $76M, with $850M in cash. Management expects continued cash pay pressure but sees growth in insurance.

Original reporting
Published Oct 29, 2026, 7:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 7:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Teladoc Health Inc (TDOC) (Q3 2026) Earnings Call Highlights: Integrated Care Margin — source image
Decision brief

The 30-second read

$TDOCNeutralMed
01

Why it matters

The earnings beat on adjusted EBITDA suggests short‑term price support, but revenue weakness tempers enthusiasm.

02

Market read

First report of Teladoc's Q3 2026 results; material numbers for a mid‑cap digital health company.

03

What to watch

Insurance‑driven growth and therapist capacity expansion may improve future margins.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Teladoc Health released its Q3 2026 earnings call transcript, highlighting performance metrics and guidance.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

Q3 2026 revenue of $605M near guidance and adjusted EBITDA of $79M beat the high end, with margin expansion to 18.8%.

Expected impact

potential modest upside as the EBITDA beat offsets revenue weakness

Evidence & confidence

Investors focus on profitability beat; however, revenue fell YoY, limiting upside.

Market effects

Telehealth sector may see renewed interest in integrated‑care profitability models.

U.S. healthcare stocks could experience modest ripple effects.

Limited to investors tracking digital health earnings trends.

Counterpoint

Revenue decline and cash‑pay pressure could signal longer‑term headwinds.

Key entities

  • Charles Divita

    CEO of Teladoc Health, provided commentary on earnings and outlook.

  • Mike Grasher

    CFO of Teladoc Health, discussed financial results.

Related articles

$TDOCHighAI 8/10

Teladoc (TDOC) stock trades up, here is why

Teladoc Health (TDOC) shares rose 24.2% after Q3 results beat revenue and adjusted EBITDA forecasts. Revenue was $605.1M, net loss narrowed to $26.9M. The company exceeded Wall Street expectations, boosting investor confidence. TDOC is up 22.7% YTD but remains 11% below its 52-week high.

$TDOCHighAI 8/10

Teladoc Health Q3 Earnings Call Highlights

Teladoc Health (TDOC) reported Q3 results, with BetterHelp revenue down 12.8% YoY to $207M, but insurance revenue grew to $32M. The company raised its 2026 revenue outlook to $2.39B-$2.44B and expects BetterHelp insurance revenue to reach $99M-$105M. TDOC plans to address $1B in convertible notes maturing in 2027.